Emil Frei
- Oncology top 0.1%
- Cancer Treatment and Pharmacology 47
- Neutropenia and Cancer Infections 23
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 30
- Cancer Research top 0.5%
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 21
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 26
-
- Acute Lymphoblastic Leukemia research 36
-
- Lung Cancer Treatments and Mutations 33
-
- Cancer therapeutics and mechanisms 24
- Co-authors
- Emil J. FreireichGeorge P. CanellosJames K. LuceD H HoPaul P. CarboneJACQUELINE WHANGGerald P. BodeyA. Rosowsky
- Cited by
- OncologyHematologyCancer Research
- Journals
- Cancer (33 papers)New England Journal of Medicine (14 papers)Journal of Clinical Oncology (13 papers)
- Partner nations
- United StatesUnited KingdomMalaysia
In The Last Decade
Emil Frei
265 papers receiving 14.1k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Oncology 7.3k
- Hematology 2.4k
- Cancer Research 2.0k
- Genetics 1.4k
- Pathology and Forensic Medicine 1.9k
Countries citing papers authored by Emil Frei
This map shows the geographic impact of Emil Frei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Frei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Frei more than expected).
Fields of papers citing papers by Emil Frei
This network shows the impact of papers produced by Emil Frei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Frei. The network helps show where Emil Frei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emil Frei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 19 | |
| 2 | Confrontation, passion, and personalization. Emil J. Freireich. | 1997 | 2 |
| 3 | 1993 | 3 | |
| 4 | 1993 | 67 | |
| 5 | 1992 | 15 | |
| 6 | The Regulation of proliferation and differentiation in normal and neoplastic cells | 1989 | 6 |
| 7 | 1989 | 134 | |
| 8 | 1988 | 42 | |
| 9 | Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppressionbreakdown → | 1988 | 538 |
| 10 | Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat. | 1978 | 41 |
| 11 | Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate. | 1976 | 53 |
| 12 | Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. | 1976 | 30 |
| 13 | Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts. | 1975 | 43 |
| 14 | Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors. | 1973 | 31 |
| 15 | Summary of Informal Discussion on Clinical Obstacles to the Control of Leukemia | 1965 | 2 |
| 16 | MEHTYL-5-FLUOROOROTATE: SYNTHESIS AND COMPARISON WITH 5-FLUOROOROTIC ACID WITH RESPECT TO BIOLOGICAL ACTIVITY AND CELL ENTRY. | 1964 | 6 |
| 17 | 1963 | 27 | |
| 18 | 1962 | 47 | |
| 19 | Clinical Studies of 6-Azauracil | 1960 | 31 |
| 20 | Clinical Trial of the Cytostatic Agent A-139 (2,5-Bis[1-Aziridinyl]-3,6-bis[2-methoxyethoxy]-p-benzoquinone) | 1960 | 2 |
About Emil Frei
Emil Frei is a scholar working on Hematology, Oncology, Genetics, Cancer Research and Pathology and Forensic Medicine, having authored 272 papers that have together received 15.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (47 papers), Acute Lymphoblastic Leukemia research (36 papers), Lung Cancer Treatments and Mutations (33 papers), Acute Myeloid Leukemia Research (30 papers), Lymphoma Diagnosis and Treatment (26 papers), Cancer therapeutics and mechanisms (24 papers), Neutropenia and Cancer Infections (23 papers) and Chronic Lymphocytic Leukemia Research (21 papers). The work is most often cited by research in Oncology (7.3k citations), Hematology (2.4k citations), Cancer Research (2.0k citations), Genetics (1.4k citations) and Pathology and Forensic Medicine (1.9k citations). Emil Frei has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Emil J. Freireich, George P. Canellos, James K. Luce, D H Ho, Paul P. Carbone, JACQUELINE WHANG, Gerald P. Bodey, A. Rosowsky, Robert W. Carey and Lowell E. Schnipper. Their work appears in journals such as Cancer, New England Journal of Medicine, Journal of Clinical Oncology, Blood and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.